MSH6 and neoplasm: Individuals whose tumours are proficient for MLH1, but abnormal for one or more of the other MMR proteins (MSH2, MSH6 or PMS2), should be offered direct referral for germline testing; tumours with MLH1 abnormality require further somatic tests.